• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    Antidepressants Linked to Lower Heart Disease

    Charlotte McLeod
    Mar. 09, 2015 04:13PM PST
    Life Science Investing

    According to a Science World Report article, a new study indicates that patients treated with antidepressants have lower lower mortality rates, as well as lower stroke and artery disease when compared to patients not treated with such medication.

    According to a Science World Report article, a new study indicates that patients treated with antidepressants have lower lower mortality rates, as well as lower stroke and artery disease when compared to patients not treated with such medication.

    As quoted in the market news:

    The study, based on three years of research, involved about 5,311 people who were affected by severe depression out of over 26,000 patients who were treated at the involved medical facility. The results showed that 20 percent had moderate or severe depression while the remaining 21,517 patients didn’t show depression based on a 9-question depression screen.

    Heidi May, the lead author of the study and a public health scientist, commented:

    This study demonstrates the importance of evaluating patients for depression,not only in terms of improving their mood, but reducing their risk for heartdisease.

    Antidepressants were not associated with a reduced cardiovascular risk in people with little or no depression, but in moderately to severely depressed people, antidepressants were shown to significantly improve cardiovascular outcomes. We thought we’d see an additive effect.

    Click here to read the full Science World Report article.

    life-science-investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Albert Labs

    Albert Labs

    AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025

    AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025

    Latest News

    Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

    Lobe Sciences Reports First Quarter 2026 Results and Highlights

    Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

    Expansion of SVN-015 into Depression Following Positive Preclinical Data

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES